Anthos Therapeutics

Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cardiovascular and metabolic diseases. They are particularly dedicated to advancing a novel anticoagulant therapy called abelacimab, a Factor XI inhibitor, which is currently in late-stage clinical trials. Their mission is to redefine cardiovascular care with pioneering therapies that inspire hope and healing for patients. They prioritize patients by upholding the highest ethical standards, pursuing groundbreaking research, and striving for excellence in execution.

Anthos Therapeutics is a transformative company with a focus on addressing critical unmet needs in vulnerable populations. They are committed to pushing the boundaries of innovation and establishing a new benchmark in anticoagulation treatment to improve the lives of patients worldwide. The company is led by a world-class executive team with extensive experience in the development and commercialization of pharmaceuticals. Anthos Therapeutics is backed by Blackstone Life Sciences, which provides the company with scale capital and operational leadership to bring promising new medicines to market.

Anthos Therapeutics provides a comprehensive benefits package that includes a subsidized health, dental, vision, and life insurance plan, sick pay, four weeks of accrued vacation, and fourteen paid holidays, including a company-wide shutdown between Christmas and New Year's.

Anthos Therapeutics offers a comprehensive benefits package that is subsidized 80% by the company. This includes health, dental, vision, and life insurance. To ensure a healthy work-life balance, employees are provided with sick pay, four weeks of accrued vacation, and 14 holidays, including a companywide shutdown between Christmas and New Year’s.

Anthos Therapeutics is a clinical-stage biopharmaceutical company dedicated to redefining cardiovascular care with pioneering therapies that inspire hope and healing for patients and their caregivers. Committed to addressing critical unmet needs in vulnerable populations with urgency, Anthos strives for unparalleled excellence across all aspects of its work, with the immediate goal of establishing a new benchmark in anticoagulation treatment to improve the lives of patients worldwide.

Anthos Therapeutics promotes a culture that prioritizes patient well-being, ethical conduct, and continuous innovation. They value integrity and transparency in all aspects of their work, fostering a collaborative environment that encourages teamwork and intellectual curiosity. The company emphasizes excellence in execution and is committed to addressing critical unmet needs in vulnerable populations with urgency.

Anthos Therapeutics is committed to building a diverse, equitable, and inclusive workplace. The company values respect, inclusion, and effective communication as a way to foster teamwork and achieve success together. Anthos Therapeutics actively seeks talented professionals from all backgrounds and is committed to creating a welcoming and supportive environment for all employees.